Gary Charles Robb

Companies

• Corcept TherapeuticsChief Business Officer Mar 3, 2021 to now¹
• Corcept TherapeuticsChief financial officer Sep 12, 2011 to Apr 27, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCorcept Therapeutics CORT53,772 shares³$5.9M at $110.16Sep 28, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 24, 2026Gift 5,000 shares of Corcept Therapeutics³
• Sep 24, 2026Gift 5,000 shares of Corcept Therapeutics³
• Sep 24, 2026Gift 17,100 shares of Corcept Therapeutics³
• Sep 17, 2026Exercised options 17,493 shares at $8.27 of Corcept Therapeutics⁴
• Sep 2, 2026Shares withheld for tax 91 shares at $113.38 of Corcept Therapeutics⁵
• Sep 1, 2026Granted 164 shares of Corcept Therapeutics⁵
• Sep 1, 2026Granted 164 shares at $113.38 of Corcept Therapeutics⁵
• Aug 17, 2026Sold 10,000 shares at $116.26 of Corcept Therapeutics⁶
• Aug 17, 2026Gift 125 shares of Corcept Therapeutics⁶
• Aug 12, 2026Gift 3,000 shares of Corcept Therapeutics⁷
• Aug 12, 2026Gift 3,000 shares of Corcept Therapeutics⁷
• Aug 12, 2026Gift 11,530 shares of Corcept Therapeutics⁷
• Jun 2, 2026Shares withheld for tax 358 shares at $70.44 of Corcept Therapeutics⁸
• Jun 1, 2026Granted 776 shares of Corcept Therapeutics⁸
• Jun 1, 2026Granted 776 shares at $70.44 of Corcept Therapeutics⁸
• May 27, 2026Gift 600 shares of Corcept Therapeutics⁹
• May 13, 2026Gift 1,000 shares of Corcept Therapeutics¹⁰
• May 13, 2026Gift 1,000 shares of Corcept Therapeutics¹⁰
• May 13, 2026Gift 5,300 shares of Corcept Therapeutics¹⁰
• Mar 3, 2026Shares withheld for tax 121 shares at $35.97 of Corcept Therapeutics¹¹
• Mar 2, 2026Granted 499 shares of Corcept Therapeutics¹¹
• Mar 2, 2026Granted 499 shares at $35.97 of Corcept Therapeutics¹¹
• Dec 24, 2025Shares withheld for tax 80,284 shares at $83.59 of Corcept Therapeutics¹²
• Dec 24, 2025Exercised options 145,000 shares at $3.88 of Corcept Therapeutics¹²
• Dec 2, 2025Shares withheld for tax 148 shares at $79.78 of Corcept Therapeutics¹³